More recently, in studies of p17 from human non-Hodgkin's lymphoma (NHL) cases, we characterized two categories of vp17s that promote B-cell growth and activate the Akt pathway: the first characterized by amino acid insertions at position 117 to 118 and the second characterized by amino acid insertions at position 125 to 126 (6). Here, AKT1 is linked to non-Hodgkin lymphoma.